Literature DB >> 18751915

Lysophospholipid activation of G protein-coupled receptors.

Tetsuji Mutoh1, Jerold Chun.   

Abstract

One of the major lipid biology discoveries in last decade was the broad range of physiological activities of lysophospholipids that have been attributed to the actions of lysophospholipid receptors. The most well characterized lysophospholipids are lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P). Documented cellular effects of these lipid mediators include growth-factor-like effects on cells, such as proliferation, survival, migration, adhesion, and differentiation. The mechanisms for these actions are attributed to a growing family of 7-transmembrane, G protein-coupled receptors (GPCRs). Their pathophysiological actions include immune modulation, neuropathic pain modulation, platelet aggregation, wound healing, vasopressor activity, and angiogenesis. Here we provide a brief introduction to receptor-mediated lysophospholipid signaling and physiology, and then discuss potential therapeutic roles in human diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18751915     DOI: 10.1007/978-1-4020-8831-5_10

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  22 in total

Review 1.  A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya).

Authors:  Jerold Chun; Volker Brinkmann
Journal:  Discov Med       Date:  2011-09       Impact factor: 2.970

Review 2.  International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.

Authors:  Jerold Chun; Timothy Hla; Kevin R Lynch; Sarah Spiegel; Wouter H Moolenaar
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 3.  Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis.

Authors:  Volker Brinkmann; Andreas Billich; Thomas Baumruker; Peter Heining; Robert Schmouder; Gordon Francis; Shreeram Aradhye; Pascale Burtin
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

Review 4.  The glycerophosphoinositols: cellular metabolism and biological functions.

Authors:  Daniela Corda; Pasquale Zizza; Alessia Varone; Beatrice Maria Filippi; Stefania Mariggiò
Journal:  Cell Mol Life Sci       Date:  2009-08-09       Impact factor: 9.261

5.  Attenuation of cocaine-induced conditioned locomotion is associated with altered expression of hippocampal glutamate receptors in mice lacking LPA1 receptors.

Authors:  Eduardo Blanco; Ainhoa Bilbao; María Jesús Luque-Rojas; Ana Palomino; Francisco J Bermúdez-Silva; Juan Suárez; Luis J Santín; Guillermo Estivill-Torrús; Antonia Gutiérrez; José Angel Campos-Sandoval; Francisco J Alonso-Carrión; Javier Márquez; Fernando Rodríguez de Fonseca
Journal:  Psychopharmacology (Berl)       Date:  2011-09-02       Impact factor: 4.530

6.  The gep proto-oncogene Gα12 mediates LPA-stimulated activation of CREB in ovarian cancer cells.

Authors:  Ji Hee Ha; Jeremy D Ward; Lakshmi Varadarajalu; Sang Geon Kim; Danny N Dhanasekaran
Journal:  Cell Signal       Date:  2013-09-19       Impact factor: 4.315

7.  Altered spatiotemporal expression of collagen types I, III, IV, and VI in Lpar3-deficient peri-implantation mouse uterus.

Authors:  Honglu Diao; John D Aplin; Shuo Xiao; Jerold Chun; Zuguo Li; Shiyou Chen; Xiaoqin Ye
Journal:  Biol Reprod       Date:  2010-09-23       Impact factor: 4.285

Review 8.  Lysophosphatidic acid (LPA) signaling in vertebrate reproduction.

Authors:  Xiaoqin Ye; Jerold Chun
Journal:  Trends Endocrinol Metab       Date:  2010-01       Impact factor: 12.015

Review 9.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

Review 10.  Lysophosphatidic acid in vascular development and disease.

Authors:  Siew T Teo; Yun C Yung; Deron R Herr; Jerold Chun
Journal:  IUBMB Life       Date:  2009-08       Impact factor: 3.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.